Cancer metabolism: Facts, fantasy, and fiction

Biochemical and Biophysical Research Communications

Volumn 313, Issue 3, 2004, Pages 459-465

  Zu, Xin Lin ^a   Guppy, Michael ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; FLUORODEOXYGLUCOSE F 18; LACTIC ACID; OXYGEN;

CANCER CELL; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER TISSUE; CELL METABOLISM; CELL TYPE; CONCEPT FORMATION; ENERGY METABOLISM; EXPERIMENTATION; GLYCOLYSIS; HUMAN; MEASUREMENT; MICROCIRCULATION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TISSUE OXYGENATION; TISSUE PREPARATION; TUMOR CELL;

EID: 0347694776     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.136     Document Type: Review

References (62)

1. Guppy M., Leedman P., Zu X.L., Russell V. Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem. J. 364:2002;309-315.
2. Warburg O. On the origin of cancer cells. Science. 123:1956;309-314.
3. Krebs H.A., Ruffo A., Johnson M., Eggleston L.V., Hems R. Oxidative phosphorylation. Biochem. J. 54:1953;107-116.
4. Ghosh S., Mukherjee K., Ray M., Ray S. Identification of a critical lysine residue at the active site in glyceraldehyde-3-phosphate dehydrogenase of Ehrlich ascites carcinoma cell. Eur. J. Biochem. 268:2001;6037-6044.
5. Karni R., Dor Y., Keshet E., Meyuhas O., Levitzki A. Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1α expression under normoxia. J. Biol. Chem. 277:2002;42919-42925.
6. Stern R., Shuster S., Neudecker B., Formby B. Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp. Cell Res. 276:2002;24-31.
7. Mathupala S.P., Heese C., Pedersen P.L. Glucose catabolism in cancer cells. J. Biol. Chem. 272:1997;22776-22780.
8. Semenza G.L., Roth H.M., Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:1994;23757-23763.
9. Lu H., Forbes R.A., Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem. 277:2002;23111-23115.
10. Burt B.M., Humm J.L., Kooby D.A., Squire O.D., Mastrorids S., Larson S.M., Fong Y. Using positron emission tomography with [18F]FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia. 3:2001;189-195.
11. Zhuang H., Cortes-Blanco A., Pourdehnad M., Adam L.-E., Yamamoto A., Martinez-Lazaro R., Lee J., Loman J., Rossman M., Alavi A. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl. Med. Commun. 22:2001;1123-1128.
12. Pauwels E.K.J., Sturm E.J.C., Bombardieri E., Cleton F.J., Stokkel M.P.M. Positron-emission tomography with [18F]flurodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. J. Cancer Res. Clin. Oncol. 126:2000;549-559.
13. Mankoff D.A., Bellon J.R. Positron-emission tomographic imaging of cancer: glucose metabolism and beyond. Semin. Radiat. Oncol. 11:2001;16-27.
14. Schirrmeister H., Kuhn T., Guhlmann A., Santijohanser C., Horster T., Nussle K., Koretz K., Glatting G., Rieber A., Kreienberg R., Buck A.C., Reske S.N. Fluorine-18 2-deoxy-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard procedures. Eur. J. Nucl. Med. 28:2001;351-358.
15. Avril N., Menzel M., Dose J., Schelling M., Weber W., Janicke F., Nathrath W., Schwaiger M. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J. Nucl. Med. 42:2001;9-16.
16. 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J. Clin. Oncol. 20:2002;379-387.
17. Miyakita H., Tokunaga M., Onda H., Usui Y., Kinoshita H., Kawamura N., Yasuda S. Significance of 18F-fluorodeoxyglucose position emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (Glut-1) expression in the cancer. Int. J. Urol. 9:2002;15-18.
18. Higashi T., Saga T., Nakamoto Y., Ishimori T., Mamede M., Wada M., Doi R., Hosotani R., Imamura M., Konishi J. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J. Nucl. Med. 43:2002;173-180.
19. Thupari J.N., Pinn M.L., Kuhajda F.P. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochem. Biophys. Res. Commun. 285:2001;217-223.
20. Chang S., Lee S., Lee C., Kim J.I., Kim Y. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder. Urology. 55:2000;448-452.
21. Wachsberger P., Gressen E., Bhala A., Bobyock S., Storck C., Coss R.A., Berd D., Leeper D.B. Variability in glucose transporter-1 levels and hexokinase activity in human melanoma. Melanoma Res. 12:2002;35-43.
22. Weinhouse S. On respiratory impairment in cancer. Science. 124:1956;267-268.
23. Ashmore J., Weber G., Landau B.R. Isotope studies on the pathway of glucose-6-phosphate metabolism in the Novikoff hepatoma. Cancer Res. 18:1958;974-979.
24. Donnelly M., Scheffler L.E. Energy metabolism in respiration-deficient and wild type Hamster fibroblast in culture. J. Cell. Physiol. 89:1976;39-52.
25. Lazo P.A. Amino acids and glucose utilization by different metabolic pathways in ascites-tumor cells. Eur. J. Biochem. 117:1981;19-25.
26. Fitzpatrick L., Jenkins A., Butler M. Glucose and glutamine metabolism of a Murine B-lymphocyte hybridoma grown in batch culture. Appl. Biochem. Biotechnol. 43:1993;93-116.
27. Mares-Perlman J.A., Shrago E. Energy substrate utilization in freshly isolated Morris hepatoma 7777 cells. Cancer Res. 48:1988;602-608.
28. Newsholme P., Gordon S., Newsholme E.A. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophage. Biochem. J. 242:1987;631-636.
29. Nishimura J., Minakami S. Effect of hydrogen ion concentration on energy metabolism in pig platelets. Biochem. Biophys. Acta. 396:1975;1-10.
30. Davidheiser S., Joseph J., Davies R.E. Separation of aerobic glycolysis from oxidative metabolism and contractility in rat anococcygeus muscle. Am. J. Physiol. 247:1984;C335-C341.
31. Casey T., Pakay J., Guppy M., Arthur P.G. Hibernation in mammalian hypoxia causes down-regulation of protein and RNA synthesis in non-contracting mammalian cardiomyocytes. Circ. Res. 90:2002;777-783.
32. Siems W., Muller M., Dumdey R., Holzhutter H.-G., Rathmann J., Rapoport S.M. Quantification of pathways of glucose utilization and balance of energy metabolism of rabbit reticulocytes. Eur. J. Biochem. 124:1982;567-576.
33. Guppy M., Greiner E., Brand K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur. J. Biochem. 212:1993;95-99.
34. Abas L., Bogoyevitch M.A., Guppy M. Mitochandrial ATP production is necessary for activation of the extracellular-signal-regulated kinase during ischemia/reperfusion in rat myocyte-derived H9c2 cells. Biochem. J. 349:2000;119-126.
35. Lynch R.M., Balaban R.S. Energy metabolism of renal cell lines, A6 and MDCK: regulation by Na-K-ATPase. Am. J. Physiol. 252:1987;C225-C231.
36. Lynch R.M., Paul R.J. Compartmentation of carbohydrate metabolism in vascular smooth muscle. Am. J. Physiol. 252:1987;C328-C334.
37. Noll T., Wissenmann P., Mertens S., Krutzfeldt A., Spahr R., Piper H.M. Hypoxia tolerance of coronary endothelial cells. Adv. Exp. Med. Biol. 277:1990;467-476.
38. Guppy M., Abas L., Neylon C., Whisson M.E., Whitham S., Pethick D.W., Niu X. Fuel choices by human platelets in human plasma. Eur. J. Biochem. 244:1997;161-167.
39. Windmueller H.G., Spaeth A.E. Identification of ketone bodies and glutamine as the major respiratory fuels in vivo for postabsorptive rat small intestine. J. Biol. Chem. 253:1978;69-76.
40. Aisenberg A.C., Morris H.P. Energy pathways of Hepatoma No. 5123. Nature. 191:1961;1314-1315.
41. Lin Y.C., Elwood J.C., Rosado A., Morris H.P., Weinhouse S. Glucose metabolism in a low-glycolysing tumour the Morris Hepatoma 5123. Nature. 195:1962;153-155.
42. Elwood J.C., Lin Y.-C., Cristofalo V.J., Weinhouse S., Morris H.P. Glucose utilization in homogenates of the Morris Hepatoma 5123 and related tumors. Cancer Res. 23:1963;906-913.
43. Rodriguez-Enriquez S., Torres-Marquez E., Moreno-Sanchez R. Substrate oxidation and ATP supply in AS-30D Hepatoma cells. Arch. Biochem. Biophys. 375:2000;21-30.
44. Olavarria J.S., Chico E., Gimenez-Gallego G., Nunez De Castro I. Effect of ammonium ions on the aerobic glycolysis in Ehrlich ascites tumor cells. Biochimie. 63:1981;469-475.
45. Schmidt H., Siems W., Muller M., Dumdey R., Rapoprt S.M. ATP-producing and consuming processes of Ehrlich mouse ascites tumor cells in proliferating and resting phases. Exp. Cell Res. 194:1991;122-127.
46. +)-ATPase in cultured cells. Biochim. Biophys. Acta. 804:1984;419-426.
47. Medina M.A., Sanchez-Jimene F., Marquez F.J., Perez-Rodriguez J., Quessada A.R., Nunez de Castro I. Glutamine and glucose as energy substrates for Ehrlich ascites tumour cells. Biochem. Int. 16:1988;339-347.
48. Lanks K.W., Hitti I.F., Chin N.W. Substrate utilization for lactate energy production by heat-shocked L929 cells. J. Cell. Physiol. 127:1986;451-456.
49. Guppy M., Kong S.-E., Niu X., Busfield S., Klinken P. Method for measuring a comprehensive energy budget in a proliferating cell system over multiple cell cycle. J. Cell. Physiol. 170:1997;1-7.
50. Kallinowski F., Schlenger K.H., Runkel S., Kloes M., Stohrer M., Okunieff P., Vaupel P. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res. 49:1989;3759-3764.
51. Kallinowski F., Fortmeyer H.P., Vaupel P. Substrate utilization of human xenografts in vivo. J. Nutr. Growth Cancer. 4:1987;155-166.
52. Kallinowski F., Vaupel P., Runkel S., Berg H.P., Fortmeyer H.P., Baessler K.H., Wagner K., Mueller-Klieser W., Walenta S. Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. Cancer Res. 48:1988;7264-7272.
53. Kallinowski F., Schlenger K.H., Kloes M., Stohrer M., Vaupel P. Tumor blood flow: the principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo. Int. J. Cancer. 44:1989;266-272.
54. Sauer L.A., Stayman III W.J., Dauchy R.T. Amino acid, glucose and lactate acid utilization in vivo by rat tumors. Cancer Res. 42:1982;4090-4097.
55. 2 extraction is key parameter determining the oxygenation status of malignant tumors and normal tissues. Int. J. Oncol. 22:2003;795-798.
56. Vaupel P., Thews O., Kellether D.K., Hoeckel M. Current status of knowledge and critical issues in tumor oxygenation - results from 25 years research in tumor pathophysiology. Adv. Exp. Med. Biol. 454:1998;591-602.
57. Guppy M. The hypoxia core: a possible answer to the cancer paradox. Biochem. Biophys. Res. Commun. 299:2002;676-680.
58. Rak J., Yu J.L., Kerbel R.S., Coomber B.L. What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors? Cancer Res. 62:2002;1931-1934.
59. Giatromanolaki A., Harris A. Tumour hypoxia, hypoxia signaling pathway and hypoxia inducible factor expression in human cancer. Anticancer Res. 21:2001;4324-4327.
60. Brown J.M. The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res. 59:1999;5863-5870.
61. Koshikawa N., Takenaga K., Tagawa M., Sakiyama S. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells. Cancer Res. 60:2000;2936-2941.
62. Burgman P., O'Donoghue J.A., Humm J.L., Ling C.C. Hypoxia-induced increase in FDG uptake in MCF-7 cells. J. Nucl. Med. 42:2001;170-175.